DDIT3 and neoplasm: It has been demonstrated that trabectedin downregulates abnormal transcription factor expression, such as the rearranged genes FUS-CHOP or EWS-CHOP that characterize MLS, and modulates the production of cytokines and chemokines causing a profound alteration of tumor microenvironment [17, 18].